FDA Adverse Event Injury Summary report: N

UNKNOWN DEPUY ASR HIP

MDR report key: 2060645 · Received April 6, 2011

Report

Report Number
1818910-2011-05346
Event Type
Injury
Date Received
April 6, 2011
Date of Event
November 14, 2010
Report Date
March 7, 2011
Manufacturer
DEPUY INTERNATIONAL LTD.8010379
Product Code
KWA
PMA / PMN Number
NA
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGAL SYSTEM) COMPLAINT NUMBER DINT 16289. REASON FOR ORIGINAL COMPLAINT ¿ ASR REVISION HIP(S) TO BE REVISED: LEFT TYPE OF HIP REPLACEMENT PRODUCT: ASR HIP RESURFACING SYSTEM REASON(S) FOR REVISION: PAIN AND ALVAL SOFT TISSUE REACTION THE REPORTED EVENT HAS BEEN EVALUATED AND WILL BE MONITORED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

THE PT HAS HAD AN ASR REVISION. SPECIFIC DETAILS REGARDING THE REPORT ARE UNK.

Description of Event or Problem · 1

REASON(S) FOR REVISION: PAIN AND ALVAL SOFT TISSUE REACTION

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNKNOWN DEPUY ASR HIP 87KWA KWA DEPUY INTERNATIONAL LTD.8010379 NA UNK

Patients

Seq Age Sex Outcome Treatment
1 NA Required Intervention